Get Professional Valuation and Credit Risk Reports of Any Company in the World
New AI-Powered Free Company Valuation tool for any company in the world. Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics. Try Now for Free →
Get Professional Valuation and Credit Risk Reports of Any Company in the World
- Get an AI-powered company valuation or credit risk report in just 2 minutes
- Get reports of any company in the world with a financial statement in any language
- Upload a PDF financial statement to receive an instant report with customizable forecasts, credit score, default probability and key financial metrics
CHR. OLESEN PHARMACEUTICALS A/S — Credit Rating and Financial Key Figures
CVR number: 32090168
Jægersborg Alle 164, 2820 Gentofte
Income statement (kEUR)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 740.31 | 1 215.29 | 1 382.57 | 915.97 | 1 210.78 |
| Employee benefit expenses | - 294.29 | - 474.81 | - 531.19 | - 538.50 | - 629.76 |
| Total depreciation | -40.02 | ||||
| EBIT | 406.00 | 740.48 | 851.38 | 377.47 | 581.02 |
| Other financial income | 67.19 | 114.88 | 379.09 | 374.78 | 221.78 |
| Other financial expenses | - 151.13 | - 257.99 | - 688.77 | - 648.72 | - 497.20 |
| Pre-tax profit | 322.06 | 597.37 | 541.69 | 103.53 | 305.60 |
| Income taxes | -70.95 | - 132.13 | - 120.50 | -32.97 | -68.16 |
| Net earnings | 251.10 | 465.24 | 421.19 | 70.56 | 237.45 |
Assets (kEUR)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 4 368.41 | 4 546.43 | 3 634.49 | 2 373.50 | 3 107.77 |
| Inventories total | 4 368.41 | 4 546.43 | 3 634.49 | 2 373.50 | 3 107.77 |
| Current trade debtors | 2 465.14 | 2 575.46 | 3 768.48 | 2 909.67 | 2 070.71 |
| Current amounts owed by group member comp. | 6 088.35 | 7 759.58 | 6 351.62 | 5 278.91 | 6 010.61 |
| Prepayments and accrued income | 0.18 | 2.62 | 26.63 | 33.56 | 35.20 |
| Current other receivables | 24.22 | 91.33 | 34.47 | 135.46 | |
| Current deferred tax assets | 9.45 | 9.45 | 9.45 | ||
| Short term receivables total | 8 587.35 | 10 347.11 | 10 247.51 | 8 256.61 | 8 251.98 |
| Cash and bank deposits | 2.35 | 92.43 | 182.95 | 206.05 | |
| Cash and cash equivalents | 2.35 | 92.43 | 182.95 | 206.05 | |
| Balance sheet total (assets) | 12 958.11 | 14 985.98 | 14 064.96 | 10 836.16 | 11 359.75 |
Equity and liabilities (kEUR)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 79.17 | 79.17 | 79.17 | 79.17 | 79.17 |
| Shares repurchased | 300.00 | 150.00 | |||
| Other reserves | - 200.00 | ||||
| Retained earnings | 520.00 | 771.10 | 1 236.34 | 1 357.53 | 1 278.09 |
| Profit of the financial year | 251.10 | 465.24 | 421.19 | 70.56 | 237.45 |
| Shareholders equity total | 850.27 | 1 315.51 | 1 736.70 | 1 607.26 | 1 744.71 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 10 217.41 | 10 843.99 | 10 864.75 | 3 911.18 | 3 879.02 |
| Current trade creditors | 775.01 | 1 621.55 | 568.96 | 848.40 | 950.62 |
| Current owed to group member | 881.64 | 771.03 | 570.62 | 4 161.73 | 4 385.48 |
| Short-term deferred tax liabilities | 211.03 | 343.15 | 252.08 | 275.63 | 343.50 |
| Other non-interest bearing current liabilities | 22.75 | 90.75 | 71.84 | 31.96 | 56.42 |
| Current liabilities total | 12 107.84 | 13 670.47 | 12 328.25 | 9 228.90 | 9 615.04 |
| Balance sheet total (liabilities) | 12 958.11 | 14 985.98 | 14 064.96 | 10 836.16 | 11 359.75 |
CreditReports API
- Company information
- Financial data
- Credit risk data
- All 400,000+ Danish companies
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.